Samaila D et al. |
Monoterpenes enhanced the sensitivity of head and neck cancer cells to radiation treatment in vitro. |
2004 Sep-Oct |
Anticancer Res. |
pmid:15517920
|
Burke YD et al. |
Effects of the isoprenoids perillyl alcohol and farnesol on apoptosis biomarkers in pancreatic cancer chemoprevention. |
2002 Nov-Dec |
Anticancer Res. |
pmid:12530055
|
d'Alessio PA et al. |
Skin repair properties of d-Limonene and perillyl alcohol in murine models. |
2014 |
Antiinflamm Antiallergy Agents Med Chem |
pmid:24160248
|
van Beilen JB et al. |
Biocatalytic production of perillyl alcohol from limonene by using a novel Mycobacterium sp. cytochrome P450 alkane hydroxylase expressed in Pseudomonas putida. |
2005 |
Appl. Environ. Microbiol. |
pmid:15811996
|
Peffley DM et al. |
Perillyl alcohol and genistein differentially regulate PKB/Akt and 4E-BP1 phosphorylation as well as eIF4E/eIF4G interactions in human tumor cells. |
2007 |
Arch. Biochem. Biophys. |
pmid:17601486
|
da Fonseca CO et al. |
Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol. |
2008 Jul-Aug |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:18726148
|
D'Alincourt Salazar M et al. |
Intranasal administration of perillyl alcohol activates peripheral and bronchus-associated immune system in vivo. |
2014 |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:24257817
|
Imamura M et al. |
Perillyl alcohol suppresses antigen-induced immune responses in the lung. |
2014 |
Biochem. Biophys. Res. Commun. |
pmid:24309112
|
Ren Z et al. |
Inhibition of type I and type II geranylgeranyl-protein transferases by the monoterpene perillyl alcohol in NIH3T3 cells. |
1997 |
Biochem. Pharmacol. |
pmid:9296357
|
Sundin T et al. |
The isoprenoid perillyl alcohol inhibits telomerase activity in prostate cancer cells. |
2012 |
Biochimie |
pmid:22902867
|
Yamamoto Y et al. |
Synthesis of phosphatidylated-monoterpene alcohols catalyzed by phospholipase D and their antiproliferative effects on human cancer cells. |
2008 |
Bioorg. Med. Chem. Lett. |
pmid:18556205
|
Cornelissen S et al. |
Whole-cell-based CYP153A6-catalyzed (S)-limonene hydroxylation efficiency depends on host background and profits from monoterpene uptake via AlkL. |
2013 |
Biotechnol. Bioeng. |
pmid:23239244
|
Kim D and Ortiz de Montellano PR |
Tricistronic overexpression of cytochrome P450cam, putidaredoxin, and putidaredoxin reductase provides a useful cell-based catalytic system. |
2009 |
Biotechnol. Lett. |
pmid:19458919
|
Jung HJ et al. |
Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities. |
2012 |
Blood |
pmid:22294726
|
Yuri T et al. |
Perillyl alcohol inhibits human breast cancer cell growth in vitro and in vivo. |
2004 |
Breast Cancer Res. Treat. |
pmid:15026623
|
Murren JR et al. |
Phase I study of perillyl alcohol in patients with refractory malignancies. |
2002 Mar-Apr |
Cancer Biol. Ther. |
pmid:12170772
|
Bailey HH et al. |
A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days. |
2004 |
Cancer Chemother. Pharmacol. |
pmid:15205914
|
Bailey HH et al. |
Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer. |
2008 |
Cancer Chemother. Pharmacol. |
pmid:17885756
|
Azzoli CG et al. |
A phase I trial of perillyl alcohol in patients with advanced solid tumors. |
2003 |
Cancer Chemother. Pharmacol. |
pmid:12695855
|
Morgan-Meadows S et al. |
Phase I trial of perillyl alcohol administered four times daily continuously. |
2003 |
Cancer Chemother. Pharmacol. |
pmid:12904896
|